| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.042 | 0.5 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.035 | 0.5 |